Shawn E. Lupold

4.9k citations

58 papers · 3.9k indexed · h-index 26

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 2%
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- Circular RNAs in diseases

Papers in

Cancer Research 13
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 8
Molecular Biology 42
- RNA Interference and Gene Delivery 15
- Advanced biosensing and bioanalysis techniques 8
- Circular RNAs in diseases 7

Co-authors: Mark Castanares Xiaohua Ni Yun Lin Donald S. Coffey Brian J. Hicke Judit Ribas Wasim H. Chowdhury Kathleen Forrester
Journals: The Prostate (5 papers)Cancer Research (4 papers)Nucleic Acids Research (3 papers)Molecular Cancer Therapeutics (3 papers)Molecular Therapy (3 papers)
Partner nations: United States China Czechia

In The Last Decade

Shawn E. Lupold

58 papers receiving 3.8k citations

Peers

Countries citing papers authored by Shawn E. Lupold

Since Specialization

Citations

This map shows the geographic impact of Shawn E. Lupold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn E. Lupold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn E. Lupold more than expected).

Fields of papers citing papers by Shawn E. Lupold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn E. Lupold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn E. Lupold. The network helps show where Shawn E. Lupold may publish in the future.

Co-authors

The 25 scholars most cited alongside Shawn E. Lupold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shawn E. Lupold Line = papers co-authored together Shawn E. Lupold links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Alternative polyadenylation: An untapped source for prostate cancer biomarkers and therapeutic targets? Asian journal of urology ·Akira Kurozumi, Shawn E. Lupold	2021	3
2	PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance Molecular Cancer Research ·Kenji Zennami, Su‐Mi Choi, イワオタカ, Ying Li, Wikum Dinalankara, Luigi Marchionni, Fatema H. Rafiqi, Akira Kurozumi, Koji Hatano, Shawn E. Lupold	2018	30
3	Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer Scientific Reports ·Binod Kumar, Avi Z. Rosenberg, Su‐Mi Choi, Karen Fox-Talbot, Angelo M. De Marzo, Larisa Nonn, W. Nathaniel Brennen, Luigi Marchionni, Marc K. Halushka, Shawn E. Lupold	2018	36
4	Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and Imaging Journal of Nuclear Medicine ·Sridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, Princy Parsana, Ala Lisok, Samit Chatterjee, Ronnie C. Mease, Steven P. Rowe, Shawn E. Lupold, Kenneth J. Pienta, Martin G. Pomper	2017	23
5	Development and Application of a Novel Model System to Study “Active” and “Passive” Tumor Targeting Molecular Cancer Therapeutics ·G Arnold Mulder, Binod Kumar, Koji Hatano, Luisa M. Russell, Bruce J. Trock, Peter C. Searson, Alan K. Meeker, Martin G. Pomper, Shawn E. Lupold	2016	10
6	Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer–siRNA Chimeras in Human Tumor Xenografts Molecular Cancer Therapeutics ·Xiaohua Ni, Yonggang Zhang, Kenji Zennami, Mark Castanares, G Arnold Mulder, Raju R. Raval, Haoming Zhou, Theodore L. DeWeese, Shawn E. Lupold	2015	17
7	A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation Nucleic Acids Research ·Koji Hatano, Binod Kumar, Yonggang Zhang, Jonathan B. Coulter, Mohammad Hedayati, Nadiya Navaser, Xiaohua Ni, Tarana A. Kudrolli, Wasim H. Chowdhury, Ronald Rodríguez, Theodore L. DeWeese, Shawn E. Lupold	2015	68
8	Real-time, Near-Infrared Fluorescence Imaging with an Optimized Dye/Light Source/Camera Combination for Surgical Guidance of Prostate Cancer Clinical Cancer Research ·Ching-Yi Liao, John B. Eifler, Mark Castanares, Wasim H. Chowdhury, Ying Chen, Ronnie C. Mease, Rong Ma, G Arnold Mulder, Shawn E. Lupold, Martin G. Pomper, Ronald Rodríguez	2014	49
9	Development and Screening of a Series of Antibody‐Conjugated and Silica‐Coated Iron Oxide Nanoparticles for Targeting the Prostate‐Specific Membrane Antigen ChemMedChem ·G Arnold Mulder, Thomas K. Darlington, Richard K. Baldwin, Kathryn L. Dudgeon, Christian Märkel, Prakash Kulkarni, Theodore L. DeWeese, Robert H. Getzenberg, Robert Ivkov, Shawn E. Lupold	2014	20
10	Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer Cancer Gene Therapy ·Timothy J. Johnson, Naseruddin Höti, Chang Liu, Wasim H. Chowdhury, ياسين بودريعة, Yixian Zhang, Shawn E. Lupold, Theodore L. DeWeese, Ronald Rodríguez	2013	4
11	Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts Journal of Clinical Investigation ·Xiaohua Ni, Yonggang Zhang, Judit Ribas, Wasim H. Chowdhury, Mark Castanares, Zhewei Zhang, Marikki Laiho, Theodore L. DeWeese, Shawn E. Lupold	2011	119
12	Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons Current Medicinal Chemistry ·Xiaohua Ni, Mark Castanares, Arnab Mukherjee, Shawn E. Lupold	2011	259
13	Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate‐Specific Membrane Antigen Angewandte Chemie International Edition ·Sangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, Sridhar Nimmagadda, Catherine A. Foss, Gilbert Green, James J. Fox, Shawn E. Lupold, Ronnie C. Mease, Martin G. Pomper	2011	100
14	Adenovirus Targeting to Prostate-Specific Membrane Antigen through Virus-Displayed, Semirandom Peptide Library Screening Cancer Research ·Ping Wu, Tarana A. Kudrolli, Wasim H. Chowdhury, Nicolas Franck, Ronald Rodríguez, Shawn E. Lupold	2010	15
15	Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer? BioMed Research International ·Abhinav Sidana, Muwen Wang, Wasim H. Chowdhury, Antoun Toubaji, Shabana Shabbeer, George J. Netto, Michael A. Carducci, Shawn E. Lupold, Ronald Rodríguez	2010	3
16	Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses Cancer Gene Therapy ·Naseruddin Höti, Wasim H. Chowdhury, Ch. De Beus, Judit Ribas, Mark Castanares, 常三潮田, Brittany Brown, Shawn E. Lupold, Ronald Rodríguez	2010	12
17	The transcriptional regulation of miR-21, its multiple transcripts and their implication in prostate cancer Cell Cycle ·Judit Ribas, Shawn E. Lupold	2010	99
18	miR-21: An Androgen Receptor–Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth Cancer Research ·Judit Ribas, Xiaohua Ni, Michael C. Haffner, Erik A. Wentzel, Amirali Salmasi, Wasim H. Chowdhury, Tarana A. Kudrolli, Srinivasan Yegnasubramanian, Jun Luo, Ron Rodriguez, Joshua T. Mendell, Shawn E. Lupold	2009	350
19	Valproic Acid, a Histone Deacetylase Inhibitor, Is an Antagonist for Oncolytic Adenoviral Gene Therapy Molecular Therapy ·Naseruddin Höti, Wasim H. Chowdhury, Jer‐Tsong Hsieh, Markus D. Sachs, Shawn E. Lupold, Ronald Rodríguez	2006	46
20	The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes & Development ·Xin Wei Wang, Wim Vermeulen, Jill D. Coursen, Michael K. Gibson, Shawn E. Lupold, Kathleen Forrester, Guangwen Xu, Lynne W. Elmore, Heidi Yeh, Jan H.J. Hoeijmakers, C C Harris	1996	277

About Shawn E. Lupold

Shawn E. Lupold is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 58 papers that have together received 3.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), RNA Interference and Gene Delivery (15 papers), Virus-based gene therapy research (11 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (8 papers), Advanced biosensing and bioanalysis techniques (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Circular RNAs in diseases (7 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.6k citations), Oncology (798 citations), Radiology, Nuclear Medicine and Imaging (539 citations) and Biotechnology (202 citations). Shawn E. Lupold has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Mark Castanares, Xiaohua Ni, Yun Lin, Donald S. Coffey, Brian J. Hicke, Judit Ribas, Wasim H. Chowdhury, Kathleen Forrester, Ronald Rodríguez and C C Harris. Their work appears in journals such as The Prostate, Cancer Research, Nucleic Acids Research, Molecular Cancer Therapeutics and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact